Correction to “Oncolytic Viral Therapy as Promising Immunotherapy Against Glioma”
MedComm – Future Medicine · 2026-12 · 5 (4)
DOI: 10.1002/mef2.70085 ↗At a glance
Journal article in MedComm – Future Medicine, published online on 2026-10-29. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Hu D, Tian Y, Xu J, et al. Oncolytic viral therapy as promising immunotherapy against glioma. MedComm – Future Med. 2023; 2:e61. doi:10.1002/mef2.61 In the version of this Review Article originally published, the reference list contained a duplicate reference: Reference 105 was a duplicate of Reference 208. The duplicate reference (Reference 208) should be removed. We apologize for this error.
Cite
APA
(2026). Correction to “Oncolytic Viral Therapy as Promising Immunotherapy Against Glioma”. MedComm – Future Medicine, 5(4). https://doi.org/10.1002/mef2.70085
Vancouver
Correction to “Oncolytic Viral Therapy as Promising Immunotherapy Against Glioma”. MedComm – Future Medicine. 2026;5(4). doi:10.1002/mef2.70085
BibTeX
@article{euvimed2026,
title = {Correction to “Oncolytic Viral Therapy as Promising Immunotherapy Against Glioma”},
journal = {MedComm – Future Medicine},
year = {2026},
volume = {5},
number = {4},
doi = {10.1002/mef2.70085}
}
EUVIMED